Institution · Gem Pharmaceuticals (United States)

Most cited papers from Gem Pharmaceuticals (United States)

Gem Pharmaceuticals (United States)

What are the most cited papers from Gem Pharmaceuticals (United States)?

The most cited paper from Gem Pharmaceuticals (United States) is "Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase" (Kambiz N. Alavian, Hongmei Li, Leon P. Collis et al., 2011), with 284 citations. Next come "Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma" (104) and "The Psychosocial Aspects of Complementary and Alternative Medicine" (82).

Published FieldAccess

Showing 15 of 15 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase Kambiz N. Alavian, Hongmei Li, Leon P. Collis et al. · Nature Cell Biology Open access	18 Sep 2011	284
2	Phase I Dose Finding Studies of Obatoclax (GX15-070), a Small Molecule Pan-BCL-2 Family Antagonist, in Patients with Advanced Solid Tumors or Lymphoma Jimmy J. Hwang, John G. Kuruvilla, David S. Mendelson et al. · Clinical Cancer Research Open access	10 Jun 2010	104
3	The Psychosocial Aspects of Complementary and Alternative Medicine Jacintha S. Cauffield · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	Nov 2000	82
4	Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms LesterI. Harrison, ShariL. Skinner, ThomasC. Marbury et al. · Archives of Dermatological Research	8 Apr 2004	77
5	Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer Corey Jay Langer, Istvan U. Albert, Helen J. Ross et al. · Lung Cancer	13 May 2014	71
6	Daunorubicin cardiotoxicity Susan E. Shadle, Brad P. Bammel, Barry J. Cusack et al. · Biochemical Pharmacology	Nov 2000	68
7	The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophagy Yue Wei, Tapan Mahendra Kadia, Weigang Tong et al. · Clinical Cancer Research Open access	10 Jun 2010	68
8	A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer Alberto Chiappori, Marshall T. Schreeder, M. M. Moezi et al. · British Journal of Cancer Open access	Feb 2012	51
9	Doxorubicin and C-13 Deoxydoxorubicin Effects on Ryanodine Receptor Gene Expression Hervé A. Gambliel, Briant E. Burke, Barry J. Cusack et al. · Biochemical and Biophysical Research Communications	Mar 2002	47
10	Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit model Nicole E. Frank, Barry J. Cusack, Todd T. Talley et al. · Investigational New Drugs	31 Aug 2016	25
11	Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism Barry J. Cusack, Hervé A. Gambliel, Beth Musser et al. · Cancer Chemotherapy and Pharmacology	22 Mar 2006	17
12	A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma Brian Andrew Van Tine, Mark Agulnik, Richard D. Olson et al. · Cancer Medicine Open access	23 Apr 2019	11
13	In vitro and in vivo immunosuppressive activity of a novel anthracycline, 13-deoxy, 5-iminodoxorubicin Richard D. Olson, Mark B. Headley, Alma Hodzic et al. · International Immunopharmacology Open access	27 Feb 2007	11
14	Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors Sarah A. Holstein, James C. Bigelow, Richard D. Olson et al. · Investigational New Drugs	20 Feb 2015	8
15	In Vivo Evaluation of Transdermal Iodide Microemulsion for Treating Iodine Deficiency Using Sprague Dawley Rats Alaadin Y. Alayoubi, Ryan D. Sullivan, Hao Lou et al. · AAPS PharmSciTech Open access	19 Aug 2015	3

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.